Geode Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $464K | Buy |
60,136
+1,457
| +2% | +$11.3K | ﹤0.01% | 3577 |
|
|
2025
Q1 | $349K | Buy |
58,679
+3,935
| +7% | +$23.4K | ﹤0.01% | 3671 |
|
|
2024
Q4 | $729K | Buy |
54,744
+8,024
| +17% | +$107K | ﹤0.01% | 3477 |
|
|
2024
Q3 | $380K | Buy |
46,720
+4,043
| +9% | +$32.9K | ﹤0.01% | 3694 |
|
|
2024
Q2 | $363K | Sell |
42,677
-43,667
| -51% | -$371K | ﹤0.01% | 3689 |
|
|
2024
Q1 | $1.5M | Buy |
86,344
+338
| +0.4% | +$5.87K | ﹤0.01% | 3224 |
|
|
2023
Q4 | $1.1M | Buy |
86,006
+2,943
| +4% | +$37.7K | ﹤0.01% | 3321 |
|
|
2023
Q3 | $3.07M | Buy |
83,063
+1,801
| +2% | +$66.6K | ﹤0.01% | 2889 |
|
|
2023
Q2 | $3.27M | Buy |
81,262
+4,679
| +6% | +$188K | ﹤0.01% | 2920 |
|
|
2023
Q1 | $5.55M | Buy |
76,583
+2,838
| +4% | +$206K | ﹤0.01% | 2590 |
|
|
2022
Q4 | $6.05M | Buy |
73,745
+2,892
| +4% | +$237K | ﹤0.01% | 2566 |
|
|
2022
Q3 | $6.7M | Buy |
70,853
+2,395
| +3% | +$226K | ﹤0.01% | 2515 |
|
|
2022
Q2 | $13.3M | Buy |
68,458
+1,214
| +2% | +$236K | ﹤0.01% | 2045 |
|
|
2022
Q1 | $15.6M | Buy |
67,244
+2,425
| +4% | +$563K | ﹤0.01% | 2053 |
|
|
2021
Q4 | $25.5M | Buy |
64,819
+5,906
| +10% | +$2.33M | ﹤0.01% | 1788 |
|
|
2021
Q3 | $26.4M | Sell |
58,913
-1,660
| -3% | -$743K | ﹤0.01% | 1764 |
|
|
2021
Q2 | $23.5M | Buy |
60,573
+3,796
| +7% | +$1.48M | ﹤0.01% | 1856 |
|
|
2021
Q1 | $20.4M | Buy |
56,777
+8,595
| +18% | +$3.09M | ﹤0.01% | 1864 |
|
|
2020
Q4 | $23.6M | Buy |
48,182
+5,645
| +13% | +$2.77M | ﹤0.01% | 1614 |
|
|
2020
Q3 | $13.8M | Buy |
42,537
+7,150
| +20% | +$2.32M | ﹤0.01% | 1770 |
|
|
2020
Q2 | $12.9M | Buy |
35,387
+2,278
| +7% | +$830K | ﹤0.01% | 1782 |
|
|
2020
Q1 | $7.04M | Buy |
33,109
+3,771
| +13% | +$802K | ﹤0.01% | 1946 |
|
|
2019
Q4 | $12.1M | Buy |
29,338
+1,478
| +5% | +$609K | ﹤0.01% | 1878 |
|
|
2019
Q3 | $9.83M | Buy |
27,860
+3,981
| +17% | +$1.41M | ﹤0.01% | 1943 |
|
|
2019
Q2 | $12M | Buy |
23,879
+2,043
| +9% | +$1.03M | ﹤0.01% | 1809 |
|
|
2019
Q1 | $21.7M | Buy |
21,836
+1,913
| +10% | +$1.9M | 0.01% | 1359 |
|
|
2018
Q4 | $17.3M | Buy |
19,923
+1,862
| +10% | +$1.62M | 0.01% | 1386 |
|
|
2018
Q3 | $18.7M | Buy |
18,061
+1,034
| +6% | +$1.07M | 0.01% | 1461 |
|
|
2018
Q2 | $15.6M | Buy |
17,027
+2,957
| +21% | +$2.72M | ﹤0.01% | 1539 |
|
|
2018
Q1 | $13.7M | Buy |
14,070
+6,196
| +79% | +$6.04M | ﹤0.01% | 1533 |
|
|
2017
Q4 | $3.56M | Buy |
7,874
+190
| +2% | +$86K | ﹤0.01% | 2417 |
|
|
2017
Q3 | $3.18M | Buy |
7,684
+147
| +2% | +$60.8K | ﹤0.01% | 2472 |
|
|
2017
Q2 | $2.64M | Buy |
7,537
+591
| +9% | +$207K | ﹤0.01% | 2571 |
|
|
2017
Q1 | $3.57M | Buy |
6,946
+290
| +4% | +$149K | ﹤0.01% | 2316 |
|
|
2016
Q4 | $2.36M | Buy |
6,656
+797
| +14% | +$283K | ﹤0.01% | 2531 |
|
|
2016
Q3 | $3.13M | Buy |
5,859
+350
| +6% | +$187K | ﹤0.01% | 2271 |
|
|
2016
Q2 | $3.1M | Buy |
5,509
+394
| +8% | +$222K | ﹤0.01% | 2199 |
|
|
2016
Q1 | $2.43K | Sell |
5,115
-175
| -3% | -$83 | ﹤0.01% | 2334 |
|
|
2015
Q4 | $3.49M | Buy |
5,290
+454
| +9% | +$300K | ﹤0.01% | 2125 |
|
|
2015
Q3 | $3.8M | Buy |
4,836
+2,259
| +88% | +$1.78M | ﹤0.01% | 2016 |
|
|
2015
Q2 | $3.4M | Buy |
2,577
+297
| +13% | +$392K | ﹤0.01% | 2163 |
|
|
2015
Q1 | $2.37M | Buy |
2,280
+873
| +62% | +$907K | ﹤0.01% | 2337 |
|
|
2014
Q4 | $941K | Buy |
+1,407
| New | +$941K | ﹤0.01% | 2882 |
|